Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA1 | P00915 | 2/20 | 0.36 |
| ▸ | CA2 | P00918 | 2/20 | 0.36 |
| ▸ | NPC1 | O15118 | 6/20 | 0.32 |
| ▸ | HTT | P42858 | 6/20 | 0.32 |
| ▸ | KDM4E | B2RXH2 | 5/20 | 0.32 |
| ▸ | RAB9A | P51151 | 5/20 | 0.32 |
| ▸ | SMN1; SMN2 | Q16637 | 5/20 | 0.32 |
| ▸ | MEN1 | O00255 | 5/20 | 0.32 |
| ▸ | KMT2A | Q03164 | 5/20 | 0.32 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.32 |
| ▸ | GAA | P10253 | 4/20 | 0.32 |
| ▸ | GLA | P06280 | 1/20 | 0.32 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.32 |
| ▸ | RCE1 | Q9Y256 | 1/20 | 0.32 |
| ▸ | NPSR1 | Q6W5P4 | 3/20 | 0.32 |
| ▸ | LMNA | P02545 | 2/20 | 0.32 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.32 |
| ▸ | RAD52 | P43351 | 2/20 | 0.32 |
| ▸ | RGS12 | O14924 | 1/20 | 0.32 |
| ▸ | USP2 | O75604 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL413172 | 0.92 | CA1 (0.44) | CA1CA2NPC1HTTKDM4E | |
| SCHEMBL486848 | 0.88 | — | — | |
| Hydrochloric Acid SCHEMBL30980141 | 0.79 | KMT2A (0.33) | CA1CA2NPC1HTTRAB9A | |
| SCHEMBL412839 | 0.79 | — | — | |
| SCHEMBL532146 | 0.76 | CA1 (0.30) | CA1CA2 | |
| SCHEMBL413468 | 0.68 | CA1 (0.36) | CA1CA2HTTPTPN1 | |
| Hydrochloric Acid SCHEMBL30980118 | 0.65 | POLB (0.34) | NPC1HTTKDM4ERAB9ASMN1; SMN2 | |
| SCHEMBL329375 | 0.65 | CA1 (0.33) | CA1CA2NPC1HTTRAB9A | |
| SCHEMBL28239043 | 0.65 | CA1 (0.51) | CA1CA2NPC1HTTKDM4E | |
| SCHEMBL294424 | 0.65 | CA1 (0.51) | CA1CA2NPC1HTTKDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 109 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3207013-A1 | METHOD FOR SEPARATING HF FROM HF/HALOGENATED HYDROCARBON MIXTURES USING IONIC LIQUIDS | Honeywell International Inc. (US) | 2017-08-23 | — | — | EP | claimed |
| EP-3057928-A1 | PROCESS FOR PRODUCING 1-CHLORO-3,3,3-TRIFLUOROPROPENE IN AN IONIC LIQUID | Honeywell International Inc. (US) | 2016-08-24 | — | — | EP | claimed |
| WO-2016061294-A1 | METHOD FOR SEPARATING HF FROM HF/HALOGENATED HYDROCARBON MIXTURES USING IONIC LIQUIDS | HONEYWELL INTERNATIONAL INC. (US) | 2016-04-21 | — | — | WO | claimed |
| US-20160107892-A1 | METHOD FOR SEPARATING HF FROM HF/HALOGENATED HYDROCARBON MIXTURES USING IONIC LIQUIDS | HONEYWELL INTERNATIONAL INC. (US) | 2016-04-21 | — | — | US | claimed |
| US-9272967-B2 | Process for producing 1-chloro-3,3,3-trifluoropropene in an ionic liquid | HONEYWELL INTERNATIONAL INC. (US) | 2016-03-01 | — | — | US | claimed |
| EP-2356182-B1 | RADIATION CURABLE COATING MATERIALS | BASF SE (DE) | 2015-05-06 | — | — | EP | claimed |
| WO-2015057476-A1 | PROCESS FOR PRODUCING 1-CHLORO-3,3,3-TRIFLUOROPROPENE IN AN IONIC LIQUID | HONEYWELL INTERNATIONAL INC. (US) | 2015-04-23 | — | — | WO | claimed |
| US-20150105596-A1 | PROCESS FOR PRODUCING 1-CHLORO-3,3,3-TRIFLUOROPROPENE IN AN IONIC LIQUID | SOLSTICE ADVANCED MATERIALS US, INC. | 2015-04-16 | — | — | US | claimed |
| US-8946442-B2 | Foamed ionic compounds | E I DU PONT DE NEMOURS AND COMPANY (US) | 2015-02-03 | — | — | US | claimed |
| US-20130299736-A1 | RADIATION-CURABLE COATING MATERIALS | BASE SE (DE) | 2013-11-14 | — | — | US | claimed |
| US-20110230617-A1 | RADIATION-CURABLE COATING MATERIALS | BASF SE (DE) | 2011-09-22 | — | — | US | claimed |
| EP-2356182-A1 | RADIATION CURABLE COATING MATERIALS | BASF SE (DE) | 2011-08-17 | — | — | EP | claimed |
| WO-2010055050-A1 | RADIATION CURABLE COATING MATERIALS | BASF SE (DE) | 2010-05-20 | — | — | WO | claimed |
| WO-2008058885-A2 | RADIATION-HARDENABLE COATING MASSES | BASF SE (DE) | 2008-05-22 | — | — | WO | claimed |
| EP-1663921-B1 | METHOD FOR PRODUCING HALOALKANES FROM ALCOHOLS | BASF AG (DE) | 2007-05-02 | — | — | EP | claimed |
| US-20070055084-A1 | Method for producing haloalkanes from alcohols | BASF AKTIENGESELLSCHAFT (DE) | 2007-03-08 | — | — | US | claimed |
| EP-1663921-A2 | METHOD FOR PRODUCING HALOALKANES FROM ALCOHOLS | BASF AKTIENGESELLSCHAFT (DE) | 2006-06-07 | — | — | EP | claimed |
| WO-2005026089-A2 | METHOD FOR PRODUCING HALOALKANES FROM ALCOHOLS | BASF AKTIENGESELLSCHAFT (DE) | 2005-03-24 | — | — | WO | claimed |
| CN-109415452-B | Method for producing highly reactive isobutene homo-or copolymers | 巴斯夫欧洲公司 | 2021-10-26 | — | — | CN | disclosed |
| US-20040133058-A1 | Ionic liquids as selective additives for separation of close-boiling or azeotropic mixtures | BASF AKTIENGESELLSCHAFT (DE) | 2004-07-08 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040133058-A1 | Ionic liquids as selective additives for separation of close-boiling or azeotropic mixtures | KCNJ6, KCNN3, KCNN2 | CA1 714/4885CA2 166/4885NPC1 1689/4885 |
| US-20110230617-A1 | RADIATION-CURABLE COATING MATERIALS | RAD51, MGMT, RAD54L | CA1 1469/4885CA2 3549/4885NPC1 1213/4885 |
| US-20070055084-A1 | Method for producing haloalkanes from alcohols | ADH1C, HDHD5, ADH5 | CA1 2641/4885CA2 871/4885NPC1 2128/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.